Flu-like and Other Systemic Drug Reactions among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study

Clinical Infectious Diseases

Volumn 61, Issue 4, 2015, Pages 527-535

  Sterling, Timothy R ^a   Moro, Ruth N ^b,c   Borisov, Andrey S ^b   Phillips, Elizabeth ^a,d   Shepherd, Gillian ^e   Adkinson, Newton Franklin ^f   Weis, Stephen ^g   Ho, Christine ^b   Villarino, Margarita Elsa ^b   Adkinson, N Franklin ^h   Grosset, Jacques ^h   Hackman, Judith ^h   Hamilton, Robert G ^h   Villarino, M Elsa ^h   Shang, Nong ^h   Gordin, Fred ^h   Khan, Awal ^h   Hamilton, Carol Dukes ^h   Menzies, Dick ^h   Kerrigan, Amy ^h   Horsburgh, C Robert ^h   Chaisson, Richard E ^h   McSherry, George ^h   Arevalo, Bert ^h   Vernon, Andrew ^h   Kleinbaum, David G ^h   Heilig, Charles ^h   Fryer, Kimberly ^h   Sanchez, Isabelle ^h   Lam, Suet K ^h   Scott, Nigel ^h   more..

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CDC FOUNDATION   (United States)

^d MURDOCH UNIVERSITY   (Australia)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^h NONE

Author keywords

adverse drug reaction; flu like syndrome; isoniazid; rifapentine; treatment of latent M. tuberculosis infection

Indexed keywords

ISONIAZID; RIFAPENTINE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ANAPHYLAXIS; ARTICLE; BODY MASS; CHILL; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FAINTNESS; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HIGH RISK PATIENT; HISPANIC; HUMAN; HYPOTENSION; LATENT TUBERCULOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; SKIN MANIFESTATION; SYSTEMIC DISEASE; TREATMENT DURATION; WEAKNESS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MIDDLE AGED; PATHOLOGY; RESPIRATORY TRACT DISEASES;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY TRACT DISEASES; RIFAMPIN;

EID: 84938600543     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ323     Document Type: Article

References (44)

1. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155-66.
2. Schechter M, Zajdenverg R, Falco G, et al. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 2006; 173:922-6.
3. Martinson NA, Barnes GL, Moulton LH, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011; 365: 11-20.
4. Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.MMWRMorb Mortal Wkly Rep 2011; 60:1650-3.
5. Bock NN, Sterling TR, Hamilton CD, et al. A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment. Am J Respir Crit Care Med 2002; 165:1526-30.
6. Benator D, BhattacharyaM, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomized clinical trial. Lancet 2002; 360:528-34.
7. Girling DJ. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother 1977; 3:115-32.
8. Naafs B, Matemera BO. A possible 'flu' syndrome on once-monthly rifampicin. Lepr Rev 1986; 57:271-2.
9. Martinez E, Collazos J, Mayo J. Hypersensitivity reactions to rifampin. Medicine 1999; 78:361-9.
10. Dhar S, Kaur I, Sharma VK, Kumar B. Flu syndrome due to rifampin; experience with four cases. Int J Lepr Other Mycobact Dis 1995; 63:92-4.
11. Grosset J, Leventis S. Adverse effects of rifampin. Clin Infect Dis 1983; 5:S440-6.
12. Riska NV, Mattson K. Systemic reactions to intermittent rifampicin. Bull Int Union Tuberc 1974; 49(suppl 1):280-5.
13. Riska N, Mattson K. Adverse reactions during rifampicin treatment. Scand J Respir Dis 1972; 53:87-96.
14. Salafia A, Candida. Rifampicin induced flu-syndrome and toxic psychosis. Indian J Lepr 1992; 64:537-9.
15. Aquinas M, Allan WG, Horsfall PA, et al. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1972; 1:765-71.
16. Poole G, Stradling P, Worlledge S. Potentially serious side-effects of high-dose twice-weekly rifampicin. Postgrad Med J 1971; 47:727-47.
17. Dutt AK, Moers D, SteadWW. Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis. Am Rev Respir Dis 1983; 128:419-24.
18. Shapiro M,Ward KM, Stern JJ. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. AIDS Read 2001; 11:222-6.
19. Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev 2013; 34:15-38.
20. Hong Kong Tuberculosis Treatment Services/British Medical Research Council. The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis. Tubercle 1975; 56:173-8.
21. Eule H,Werner E,Winsel K, Iwainsky H. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of sideeffects. Tubercle 1974; 55:81-9.
22. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland. Tubercle 1975; 56:1-26.
23. Motion S, Humphries MJ, Gabriel SM. Severe flu-like symptoms due to isoniazid-a report of three cases. Tubercle 1989; 70:57-60.
24. Rubira N, Baltasar MA, Marti E. Hypersensitivity syndrome from isoniazid. Allergy 1999; 54:1011-2.
25. Smith CK, Durack DT. Isoniazid and reaction to cheese. Ann Intern Med 1978; 88:520-1.
26. Pandit S, Choudhury S, Das A, Datta S, Das SK. Isoniazid-induced flulike syndrome: a rare side effect. Lung India 2013; 30:61-3.
27. Gabrail NY. Severe febrile reaction to isoniazid. Chest 1987; 91:620-1.
28. Jacobs NF Jr, Thompson SE III. Spiking fever from isoniazid simulating a septic process. JAMA 1977; 238:1759-60.
29. Crook MJ. Isoniazid-induced anaphylaxis. J Clin Pharmacol 2003; 43:545-6.
30. Cancer Therapy Evaluation Program. The revised common toxicity criteria: version 2.0. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcv20-4-30-992.pdf#search=revised common toxicity criteria. Accessed 5 May 2015.
31. Naranjo CA, Busto V, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-45.
32. Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25:5675-84.
33. Shao J. Kolmogorov-Smirov test. Mathematical Statistics. 2nd ed. New York: Springer-Verlag, 2003:446.
34. Rothman KJ, Greenland S, Lash TL. Stratification. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins, 2008:179.
35. McCulloch CE, Searle SR. GLLM with random effects. Generalized, Linear, and MixedModels. New York: JohnWiley & Sons, Inc, 2001:222.
36. Centers for Disease Control and Prevention. Body Mass Index. 2014.
37. Kaufman L, Rousseeuw PJ. Finding groups in data: an introduction to cluster analysis, 2005.
38. Patki AH, Jadhav VH, Mehta JM. 'Flu' syndrome on once monthly rifampicin. Indian J Lepr 1988; 60:84-6.
39. Hong Kong Tuberculosis Treatment Services/British Medical Research Council. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy in Hong Kong: second report-the results at 12 months. Tubercle 1974; 55:193-210.
40. Worlledge S. The detection of rifampicin-dependent antibodies. Scand J Resp Dis 1973; 84(suppl):60-3.
41. Haber E, Osborne RK. Icterus and febrile reactions in response to isonicotinic acid hydrazine; report of two cases and review of the literature. N Engl J Med 1959; 260:417-20.
42. Kaneko T, Ishigatsubo Y. Isoniazid and food interactions: fish, cheese, and wine. Intern Med 2005; 44:1120-1.
43. Miki M, Ishikawa T, Okayama H. An outbreak of histamine poisoning after ingestion of the ground saury paste in eight patients taking isoniazid in tuberculous ward. Intern Med 2005; 44:1133-6.
44. Jindani A, Harrison TS, Nunn AJ, et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med 2014; 371: 1599-608.